Malaria: How Are We Doing and How Can We Do Better?

scholarly article by Philip J Rosenthal et al published 1 February 2019 in American Journal of Tropical Medicine and Hygiene

Malaria: How Are We Doing and How Can We Do Better? is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.4269/AJTMH.18-0997
P932PMC publication ID6367613
P698PubMed publication ID30628572

P2093author name stringPhilip J Rosenthal
Chandy C John
N Regina Rabinovich
P2860cites workTools and Strategies for Malaria Control and Elimination: What Do We Need to Achieve a Grand Convergence in Malaria?Q26765029
Mapping Plasmodium falciparum Mortality in Africa between 1990 and 2015Q27198237
Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised TrialQ28553641
Pre-referral Rectal Artesunate Treatment by Community-Based Treatment Providers in Ghana, Guinea-Bissau, Tanzania, and Uganda (Study 18): A Cluster-Randomized TrialQ30151536
Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccineQ30234589
Malaria control and elimination in Sri Lanka: documenting progress and success factors in a conflict settingQ34404986
Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an opQ36478633
Dihydroartemisinin-Piperaquine for the Prevention of Malaria in PregnancyQ36843561
Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African ChildrenQ37130595
Artemisinin-Resistant Plasmodium falciparum MalariaQ37193474
Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled TrialQ37480626
Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trialQ37726083
Current and Future Prospects for Preventing Malaria Transmission via the Use of InsecticidesQ38683505
Azithromycin for Malaria?Q42421033
Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.Q52615236
Effectiveness of a long-lasting piperonyl butoxide-treated insecticidal net and indoor residual spray interventions, separately and together, against malaria transmitted by pyrethroid-resistant mosquitoes: a cluster, randomised controlled, two-by-twQ52880742
Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.Q53689456
Pathway to Deployment of Gene Drive Mosquitoes as a Potential Biocontrol Tool for Elimination of Malaria in Sub-Saharan Africa: Recommendations of a Scientific Working Group†.Q55073199
Efficacy of Olyset Duo, a bednet containing pyriproxyfen and permethrin, versus a permethrin-only net against clinical malaria in an area with highly pyrethroid-resistant vectors in rural Burkina Faso: a cluster-randomised controlled trialQ56334727
Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Sporozoite Vaccine in Tanzanian AdultsQ56349366
Malaria Vaccines: Recent Advances and New HorizonsQ56362064
The antimalarial pipelineQ56379760
P275copyright licenseCreative Commons AttributionQ6905323
P6216copyright statuscopyrightedQ50423863
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectmalariaQ12156
antimalarialQ521616
eradication of infectious diseasesQ1347969
communicable disease controlQ2783798
P304page(s)239-241
P577publication date2019-02-01
P1433published inAmerican Journal of Tropical Medicine and HygieneQ15766943
P1476titleMalaria: How Are We Doing and How Can We Do Better?
P478volume100

Reverse relations

Q64062762Two successful decades of Swiss collaborations to develop new anti-malarialscites workP2860

Search more.